A Meta-Analysis of Oxidative Stress Markers in Depression
Open accessThe DOI matches its Crossref record; 124 of the 125 references it cites were found in a registry or an index.
Abstract
OBJECT: Studies have suggested that depression was accompanied by oxidative stress dysregulation, including abnormal total antioxidant capacity (TAC), antioxidants, free radicals, oxidative damage and autoimmune response products. This meta-analysis aims to analyse the clinical data quantitatively by comparing the oxidative stress markers between depressed patients and healthy controls. METHODS: A search was conducted to collect the studies that measured the oxidative stress markers in depressed patients. Studies were searched in Embase, Medline, PsychINFO, Science direct, CBMDisc, CNKI and VIP from 1990 to May 2015. Data were subjected to meta-analysis by using a random effects model for examining the effect sizes of the results. Bias assessments, heterogeneity assessments and sensitivity analyses were also conducted. RESULTS: 115 articles met the inclusion criteria. Lower TAC was noted in acute episodes (AEs) of depressed patients (p<0.05). Antioxidants, including serum paraoxonase, uric acid, albumin, high-density lipoprotein cholesterol and zinc levels were lower than controls (p<0.05); the serum uric acid, albumin and vitamin C levels were increased after antidepressant therapy (p<0.05). Oxidative damage products, including red blood cell (RBC) malondialdehyde (MDA), serum MDA and 8-F2-isoprostanes levels were higher than controls (p<0.05). After antidepressant medication, RBC and serum MDA levels were decreased (p<0.05). Moreover, serum peroxide in free radicals levels were higher than controls (p<0.05). There were no differences between the depressed patients and controls for other oxidative stress markers. CONCLUSION: This meta-analysis supports the facts that the serum TAC, paraoxonase and antioxidant levels are lower, and the serum free radical and oxidative damage product levels are higher than controls in depressed patients. Meanwhile, the antioxidant levels are increased and the oxidative damage product levels are decreased after antidepressant medication. The pathophysiological relationships between oxidative stress and depression, and the potential benefits of antioxidant supplementation deserve further research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Studies have reported higher levels of oxidative stress byproducts and lower levels of antioxidant enzymes (103).”
From Chronic stress, neuroinflammation, and depression: an overview of pathophysiological mechanisms and emerging anti-inflammatories (2023) · cites this paper as [103]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552 · cited 1×
“Pooled effect sizes (ES) were calculated according to DerSimonian and Laird for the random effects model because of the diversity of methods, patients’ clinical statuses and treatments [27].”
MethodStang, A. (2010) · European Journal of Epidemiology · doi:10.1007/s10654-010-9491-z · Cited by 17,396 · cited 1×
“Newcastle-Ottawa Scale (NOS) (case control studies or cohort studies) [26].”
MethodOperating characteristics of a rank correlation test for publication bias
Begg, C. B., & Mazumdar, M. (1994) · Biometrics · doi:10.2307/2533446 · Cited by 16,955
Oxidants, oxidative stress and the biology of ageing
Finkel, T., & Holbrook, N. J. (2000) · Nature · doi:10.1038/35041687 · Cited by 9,413
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
New approaches to antidepressant drug discovery: beyond monoamines
Berton, O., & Nestler, E. J. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1846 · Cited by 1,589 · cited 1×
“Depression affects millions of people and is the leading global cause of disability according to the World Health Organization [1].”
BackgroundOxidative stress in psychiatric disorders: evidence base and therapeutic implications
Ng, F., Berk, M., Dean, O., & Bush, A. I. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707008401 · Cited by 1,069 · cited 1×
“Oxidative stress is defined as a persistent imbalance between oxidation and anti-oxidation, which leads to the damage of cellular macromolecules [14, 15].”
BackgroundBilici, M., Efe, H., Köroğlu, M. A., Uydu, H. A., Bekaroğlu, M., & Değer, O. (2001) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00199-3 · Cited by 718
Meta-analysis of oxidative stress in schizophrenia.
Flatow, J., Buckley, P., & Miller, B. J. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.03.018 · Cited by 491
Research works printed but not linked: 32
- N Bal, 2012, Altered Levels of Malondialdehyde and Vitamin E in Major Depressive Disorder and Generalized Anxiety Disorder, Dusunen Adam: Journal of Psychiatry & Neurological Sciences, 25, 206
- ZP Qian, 2012, A study of correlation between serum zinc and lithium levels of depressed patients, Medical Laboratory Science and Clinics, 23, 64
- Y Chen, 2010, A study of serum IL-1β, IL-6 and blood SOD levels in patients of depression, Neural Injury and Functional Reconstruction January, 5, 74
- JM Hu, 1996, Analysis of superoxide dismutase activity of red blood cell in patients with schizophrenia and depression, Chinese Journal of Nervous and Mental Diseases, 22, 86
- ZZ Huang, 1999, Study on lipid peroxide, superoxide dismutase and glutathione peroxidase in patients with affective disorder, Chin J Psychiatry, 32, 191
- J He, 2000, The clinical study of antioxidative capacity in psychiatry patients, Chinese Journal of Behavio ral Medical Science, 9, 139
- XH Zhang, 1997, Changes of plasma SOD activity and MDA level in patients with depression and anxiety, Journal of Convalescen and Rehabilitation, 12, 157
- SL Wen, 2013, Analysis on serum levels of non-enzyme antioxidants and intelligence quotient in patients with recurrent depression, Chin Prev Med, 14, 579
- MF Chen, 2010, Analysis on serum levels of uric acid in patients with depression, Chin J Prev Chron Dis, 18, 302
- MF Chen, 2012, Plasma Non-enzyme Antioxidants Levels in the Depressive Patients with Attempted Suicide, Chin J Prev Chron Dis, 20, 529
- J Lu, 2010, The effect of escitalopram on serum glucose and lipids, Medical Journal of Chinese People’s Health, 22, 2242
- YG Yuan, 2002, Serum lipid concentrations in patients with comorbid anxiety and depression, Chin J Nerv Ment Dis, 28, 33
- YG Yuan, 2006, A study of serum lipid concentrations and apolipoprotein E genotype among patients with senile depression and alzhemier disease, Chinese General Practice, 9, 106
- YG Yuan, 2003, The relation ship between plasma monoamine neurotransmitters and serum lipid concentrations in depressive patients, J Clin Psychol Med, 13, 67
- XB Huang, 2003, Serum lipid and catecholamin concentrations in patients with anxiety and depression, J Clin Psychol Med, 13, 94
- MD Wu, 2004, A study of serum lipid concentrations in 536 patients of psychiatric disorders, Journal of Sichuan Continuing Education College of MS, 23, 175
- XH Wang, 2014, A study of physical function, serum lipids and cytokines in 48 uygur elderly patients with depression, Xinjiang Medical Journal, 44, 61
- YC Lv, 2011, Analysis of suicidal behavior and detection of biological parameter in patients with depressive disorder, Journal of Medical Forum, 32, 7
- GH Wang, 2003, The levels of the cholesterol, triglyceride, lipoprotein, apolipoprotein in young depression patients, MedicaI JournaI of Wuhan University, 24, 174
- RP Che, 2014, The study on lipid metabolism in 86 patients with first episode depression, Journal of Practical Medical Techniques, 21, 664
- WJ Zhang, 2012, The clinical study of serum thyroid hormone and lipid levels in patients with first episode depression, Chin J Lab Diagn, 16, 712
- QC Xia, 2009, Study of metabolism of glucose and lipid in patients of first-episode depressioon, J Clin Psychiatry, 19, 241
- CY Li, 2011, The comparative study on serum glucose and lipids in patients with first episode depression, Medical Journal of ChinesePeople’s Health, 23, 1355
- WL He, 2013, Research on lipid metabolism of the first-episode patients with depression, World Health Digest Medical Periodieal, 10, 413
- YM Jiao, 2006, Fasting blood glucose and serum lipid level in patients with major depression and their relations to psychopathology, Shanghai Archives of Psychiatry, 18, 266
- FX Wu, 1998, Depression and hemorheology, J Clin Psychol Med, 8, 341
- HY Yu, 1997, The mearsure of trace element in red blood cell and serum of depressed patients, Hebei Mental Health, 10, 10
- MD Fernández-González, 1998, Trace elements in serum of psychiatric outpatients, Química Clínica, 17, 208
- XR Chang, 2001, The mearsure of serum 14 kinds of trace element in patients of depression, Chinese Journal of Behavioral Medical Science, 10, 589
- XQ Guo, 2011, A study of serum ten kinds of trace element level changes in depressed patients, China Health Monthly, 1, 136
- GF Wu, 2012, A study of correlation between cytokine, serum zinc level, thyroid hormone and depression, The Public Health, 6, 61
- XW Xu, 2010, The mearsure of MAO, MDA, hs-CRP levels and their clinical meaning in patients of depression, Medical Innovation of Chin, 7, 175
Cited by
Diet and depression: Exploring the biological mechanisms of action
Marx, W., Lane, M., Hockey, M., Aslam, H., Berk, M., Walder, K., Borsini, A., Firth, J., Pariante, C. M., Berding, K., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-00925-x · Cited by 685
Hassamal, S. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1130989 · Cited by 578
“Studies have reported higher levels of oxidative stress byproducts and lower levels of antioxidant enzymes (103).”
BackgroundMolecular pathways of major depressive disorder converge on the synapse
Fries, G. R., Saldana, V. A., Finnstein, J., & Rein, T. (2023) · Molecular Psychiatry · doi:10.1038/s41380-022-01806-1 · Cited by 504
Nutritional psychiatry: The present state of the evidence
Marx, W., Moseley, G., Berk, M., & Jacka, F. (2017) · Proceedings of the Nutrition Society · doi:10.1017/s0029665117002026 · Cited by 469
“Furthermore, a recent meta-analysis of 115 studies reported lower antioxidant capacity in depressed patients during acute episodes((28)).”
The Compensatory Immune-Regulatory Reflex System (CIRS) in Depression and Bipolar Disorder
Maes, M., & Carvalho, A. F. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1016-x · Cited by 306
Oxidative Stress in Parkinson's Disease: A Systematic Review and Meta-Analysis
Wei, Z., Li, X., Li, X., Liu, Q., & Cheng, Y. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00236 · Cited by 281
“Meta-analyses from depression (Liu et al., 2015) and schizophrenia (Flatow et al.”
Salvia (Sage): A Review of its Potential Cognitive-Enhancing and Protective Effects
Lopresti, A. L. (2017) · Drugs in R&D · doi:10.1007/s40268-016-0157-5 · Cited by 209
“Oxidative stress is also elevated in many mental health disorders including major depressive disorder [41] and attentiondeficit hyperactivity disorder (ADHD) [42].”
BackgroundPeripheral Markers of Depression
Nobis, A., Zalewski, D., & Waszkiewicz, N. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9123793 · Cited by 197
“The majority of studies and meta-analyses report decreased MDA concentrations following antidepressant treatment [164,185,187,188] which correlates with clinical improvement [186,194].”
BackgroundInfluentialMitochondria, Metabolism, and Redox Mechanisms in Psychiatric Disorders
Kim, Y., Vadodaria, K. C., Lenkei, Z., Kato, T., Gage, F. H., Marchetto, M. C., & Santos, R. (2019) · Antioxidants & Redox Signaling · doi:10.1089/ars.2018.7606 · Cited by 187
Shafiee, M., Arekhi, S., Omranzadeh, A., & Sahebkar, A. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.11.020 · Cited by 182
Tolahunase, M. R., Sagar, R., Faiq, M., & Dada, R. (2018) · Restorative Neurology and Neuroscience · doi:10.3233/rnn-170810 · Cited by 167
“…(Abeetal.,2011;Jeskoetal.,2017),cortisol(Vree-burgetal.,2009),IL-6(Zhangetal.,2016),DHEAS (dehydroepiandrosteronesulfate)(Uhetal.,2017), andalsothemarkersofoxidativestress(Liuet al.,2015),DNAdamage(Czarnyetal.,2015),and telomeremetabolism(HenjeBlometal.,2015).”
Major Depression: One Brain, One Disease, One Set of Intertwined Processes
Filatova, E. V., Shadrina, M. I., & Slominsky, P. A. (2021) · Cells · doi:10.3390/cells10061283 · Cited by 160
Al-Hakeim, H. K., Al-Rubaye, H. T., Al-Hadrawi, D. S., Almulla, A. F., & Maes, M. (2023) · Molecular Psychiatry · doi:10.1038/s41380-022-01836-9 · Cited by 174
Superoxide dismutase and neurological disorders
Chidambaram, S. B., Anand, N., Varma, S. R., Ramamurthy, S., Vichitra, C., Sharma, A., Mahalakshmi, A. M., & Essa, M. M. (2024) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2023.11.007 · Cited by 174
Neuroimmune, metabolic and oxidative stress pathways in major depressive disorder
Maes, M. H. J., Almulla, A. F., You, Z., & Zhang, Y. (2025) · Nature Reviews Neurology · doi:10.1038/s41582-025-01116-4 · Cited by 158
The role of vitamin C in stress-related disorders
Moritz, B., Schmitz, A. E., Rodrigues, A. L. S., Dafre, A. L., & Cunha, M. P. (2020) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2020.108459 · Cited by 126
Greaney, J. L., Saunders, E. F. H., Santhanam, L., & Alexander, L. M. (2019) · Circulation Research · doi:10.1161/circresaha.118.313764 · Cited by 128
Huang, F., Pariante, C. M., & Borsini, A. (2022) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2021.09.021 · Cited by 117
Copper, Iron, and Manganese Toxicity in Neuropsychiatric Conditions
Tarnacka, B., Jopowicz, A., & Maślińska, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22157820 · Cited by 127
Zhou, L., Xiong, J., Chai, Y.-Q., Huang, L., Tang, Z.-Y., Zhang, X., Liu, B., & Zhang, J.-T. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.933704 · Cited by 131
Matison, A. P., Mather, K. A., Flood, V. M., & Reppermund, S. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101403 · Cited by 130
Uric acid in major depressive and anxiety disorders
Black, C. N., Bot, M., Scheffer, P. G., Snieder, H., & Penninx, B. W. J. H. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.09.003 · Cited by 124
“…are in agreement with the overall conclusion of two meta-analyses, both finding lower uric acid in depression (JiménezFernández et al., 2015; Liu et al., 2015), and the growing body of evidence for involvement of increased oxidative stress and lowered antioxidants in depression in general…”
BackgroundResultInfluentialThe Efficacy of Saffron in the Treatment of Mild to Moderate Depression: A Meta-analysis
Tóth, B., Hegyi, P. J., Lantos, T., Szakács, Z., Kerémi, B., Varga, G., Tenk, J., Pétervári, E., Balaskó, M., Rumbus, Z., et al. (2018) · Planta Medica · doi:10.1055/a-0660-9565 · Cited by 125
“Meta-analyses support that serum total antioxidant capacity and antioxidant levels might be lower, while serum free radical and oxidative damage product levels might be higher in depressed patients than in healthy controls [10,11].”
BackgroundAnderson, G. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.04.022 · Cited by 114
Evidence for Inflammation-Associated Depression
Liu, C. S., Adibfar, A., Herrmann, N., Gallagher, D., & Lanctôt, K. L. (2016) · Current topics in behavioral neurosciences · doi:10.1007/7854_2016_2 · Cited by 123
Sowa-Kućma, M., Styczeń, K., Siwek, M., Misztak, P., Nowak, R. J., Dudek, D., Rybakowski, J. K., Nowak, G., & Maes, M. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.08.024 · Cited by 104
“Different meta-analyses in MAFD have confirmed increased MDA/TBARS levels in both MAFD subtypes (Andreazza et al., 2008; Brown et al., 2014; Liu et al., 2015).”
Maes, M., Landucci Bonifacio, K., Morelli, N. R., Vargas, H. O., Barbosa, D. S., Carvalho, A. F., & Nunes, S. O. V. (2019) · Molecular Neurobiology · doi:10.1007/s12035-018-1051-7 · Cited by 102
Tayeb, A. E. K. A., Poinsignon, V., Chappell, K., Bouligand, J., Becquemont, L., & Verstuyft, C. (2023) · Antioxidants · doi:10.3390/antiox12040942 · Cited by 132
“A meta-analysis of five articles failed to show a significant difference between PCC levels in depressed patients and controls [111].”
BackgroundResultNakamura, M., Miura, A., Nagahata, T., Shibata, Y., Okada, E., & Ojima, T. (2019) · Nutrients · doi:10.3390/nu11040847 · Cited by 116
“Oxidative stress pathways may also underlie the pathophysiology of depression [21,22].”
BackgroundInfluentialAlminderej, F. M., Bakari, S., Almundarij, T. I., Snoussi, M., Aouadi, K., & Kadri, A. (2020) · Plants · doi:10.3390/plants9111534 · Cited by 117
Differences in the immune-inflammatory profiles of unipolar and bipolar depression
Brunoni, A. R., Supasitthumrong, T., Teixeira, A. L., Vieira, E. L., Gattaz, W. F., Benseñor, I. M., Lotufo, P. A., Lafer, B., Berk, M., Carvalho, A. F., et al. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.10.037 · Cited by 94
Samad, N., Jabeen, S., Imran, I., Zulfiqar, I., & Bilal, K. (2019) · Metabolic Brain Disease · doi:10.1007/s11011-019-00432-1 · Cited by 97
Ghazizadeh, J., Hamedeyazdan, S., Torbati, M., Farajdokht, F., Fakhari, A., Mahmoudi, J., Araj‐Khodaei, M., & Sadigh‐Eteghad, S. (2020) · Experimental Physiology · doi:10.1113/ep088254 · Cited by 108
“…that depressive symptoms are accompanied by increased levels of reactive oxygen species (ROS), protein oxidation and lipid peroxidation (T. Liu et al., 2015; Lopresti, 2019;Maes, Galecki, Chang, & Berk, 2011), and agents with antioxidant properties can alleviate the symptoms (S.-Y. Lee et…”
BackgroundMitochondrial dysfunction and neurological disorders: A narrative review and treatment overview
Alshial, E. E., Abdulghaney, M. I., Wadan, A. S., Abdellatif, M. A., Ramadan, N. E., Suleiman, A. M., Waheed, N., Abdellatif, M., & Mohammed, H. S. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.122257 · Cited by 98
Black, C. N., Bot, M., Scheffer, P. G., & Penninx, B. W. J. H. (2017) · Psychological Medicine · doi:10.1017/s0033291716002828 · Cited by 80
“2015), vitamin C (Liu et al. 2015) and uric acid (Jiménez-Fernández et al.”
BackgroundInfluentialSowa-Kućma, M., Styczeń, K., Siwek, M., Misztak, P., Nowak, R. J., Dudek, D., Rybakowski, J. K., Nowak, G., & Maes, M. (2018) · Neurotoxicity Research · doi:10.1007/s12640-017-9835-5 · Cited by 87
“…to DNA and mitochondrial functions, oxidative damage to membranes, including increased expression of neoantigens such as malondialdehyde (MDA) and oxidized low-density lipoprotein (LDL), and lowered antioxidant levels including zinc (review Maes et al. 2011; Liu et al. 2015; Styczeń et al. 2017).”
BackgroundResultKulczyński, B., Sidor, A., & Gramza‐Michałowska, A. (2020) · CyTA - Journal of Food · doi:10.1080/19476337.2020.1778092 · Cited by 91
“Moreover, oxidative stress, resulting from, inter alia, reduced antioxidants content in the body, can lead to the development of depression (Liu et al., 2015), eye diseases (Kruk et al., 2015) and osteoporosis (Zhou et al., 2016b).”
Camkurt, M. A., Fındıklı, E., İzci, F., Kurutaş, E. B., & Tuman, T. C. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.01.075 · Cited by 96
“, MDA was found to be increased in depressed patients, but the heterogeneity of groups were a confounding factor (Liu et al., 2015).”
BackgroundZheng, W., Zhang, Q. ‐., Cai, D. ‐., Yang, X. ‐., Qiu, Y., Ungvari, G. S., Ng, C. H., Berk, M., Ning, Y. ‐., & Xiang, Y. ‐. (2018) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12862 · Cited by 81
Endothelial dysfunction in neuroprogressive disorders—causes and suggested treatments
Morris, G., Puri, B. K., OLIVE, L. S., Carvalho, A. F., Berk, M., Walder, K. R., Gustad, L. T., & Maes, M. H. J. (2020) · BMC Medicine · doi:10.1186/s12916-020-01749-w · Cited by 93
Réus, G. Z., Fernandes, G. C., de Moura, A. B., da Silva, R. H., Darabas, A. C., de Souza, T. G., Abelaira, H. M., Carneiro, C., Wendhausen, D. L., Michels, M., et al. (2017) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2017.08.020 · Cited by 89
“Liu et al. (2015) confirmed in a meta-analysis that depressed patients, when compared to healthy controls, had oxidative damage products, including MDA, 8-F2-isoprostanes and red blood cell (RBC) damage.”
ResultBartoli, F., Trotta, G., Crocamo, C., Malerba, M. R., Clerici, M., & Carrà, G. (2017) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-017-0817-7 · Cited by 89
Lu, Z., Pu, C., Zhang, Y., Sun, Y., Liao, Y., Kang, Z., Feng, X., & Yue, W. (2022) · Antioxidants · doi:10.3390/antiox11071386 · Cited by 91
How Oxidative Stress Induces Depression?
Ji, N., Lei, M., Chen, Y., Tian, S., Li, C., & Zhang, B. (2023) · ASN NEURO · doi:10.1177/17590914231181037 · Cited by 92
“As supporting evidence, studies found significantly reduced antioxidants (e.g., SOD, GSH) and increased peroxidation biomarkers, such as carbonyl andmalondialdehyde (MDA), in depressed patients and animals (Juszczyk et al., 2021;Liu et al., 2015;Visentinet al., 2020).”
BackgroundReiter, A., Bengesser, S. A., Hauschild, A.-C., Birkl-Töglhofer, A.-M., Fellendorf, F. T., Platzer, M., Färber, T., Seidl, M., Mendel, L.-M., Unterweger, R., et al. (2020) · Nutrients · doi:10.3390/nu12092575 · Cited by 78
Almulla, A. F., Thipakorn, Y., Algon, A. A. A., Tunvirachaisakul, C., Al‐Hakeim, H. K., & Maes, M. H. J. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.08.007 · Cited by 83
Cheng, J., Dong, S., Yi, L., Geng, D., & Liu, Q. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.03.031 · Cited by 76
Almulla, A. F., Thipakorn, Y., Vasupanrajit, A., Algon, A. A. A., Tunvirachaisakul, C., Aljanabi, A. A. H., Oxenkrug, G. F., Al‐Hakeim, H. K., & Maes, M. H. J. (2022) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2022.100537 · Cited by 96
Visentin, A. P. V., Colombo, R., Scotton, E., Fracasso, D. S., Rosa, A. R., Branco, C. S., & Salvador, M. M. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/2972968 · Cited by 88
“On the other hand, higher oxidative damage products, including red blood cell (RBC) malondialdehyde, serum MDA and 8-F2-isoprostanes, and serum peroxide were found in MDD patients [138].”
BackgroundConnecting Dots between Mitochondrial Dysfunction and Depression
Khan, M., Baussan, Y., & Hébert-Chatelain, É. (2023) · Biomolecules · doi:10.3390/biom13040695 · Cited by 83
Maes, M. H. J., Bonifácio, K. L., Morelli, N. R., Vargas, H. O., Moreira, E. G., Stoyanov, D., Barbosa, D. S., Carvalho, A. F., & Nunes, S. O. V. (2018) · Neurotoxicity Research · doi:10.1007/s12640-018-9906-2 · Cited by 81
“Mood disorders, on the other hand, are characterized by enhanced nitro-oxidative pathways and highly increased aldehyde and AOPP production, while some papers report lowered uric acid in depression (Maes et al. 2011a; Liu et al. 2015; Mazereeuw et al. 2015; Andreazza et al. 2008; Brown et al. 2014; Gomes et al. 2017;…”
BackgroundCaruso, G., Fresta, C. G., Grasso, M., Santangelo, R., Lazzarino, G., Lunte, S. M., & Caraci, F. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867326666190712091515 · Cited by 71
Biological Aging and the Future of Geriatric Psychiatry
Rutherford, B. R., Taylor, W. D., Brown, P. J., Sneed, J. R., & Roose, S. P. (2017) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glw241 · Cited by 70
“Numerous studies have now reported decreased antioxidant levels and increased free radical and oxidative damage product levels in depressed patients relative to controls (45).”
BackgroundMaia, A., Oliveira, J., Lajnef, M., Mallet, L., Tamouza, R., Leboyer, M., & Oliveira‐Maia, A. J. (2019) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13026 · Cited by 74
Maes, M., Moraes, J. B., Bonifacio, K. L., Barbosa, D. S., Vargas, H. O., Michelin, A. P., & Nunes, S. O. V. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-020-00656-6 · Cited by 79
Depression and Cardiovascular Disease: The Viewpoint of Platelets
Amadio, P., Zarà, M., Sandrini, L., Ieraci, A., & Barbieri, S. S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207560 · Cited by 82
“The reduction of SOD activity associated with increased XO activity [278] and unchanged CAT activity [253,276] well explain the increased ROS generation detected in patients with depression [252, 276].”
BackgroundKanchanatawan, B., Tangwongchai, S., Sughondhabhirom, A., Suppapitiporn, S., Hemrunrojn, S., Carvalho, A. F., & Maes, M. H. J. (2018) · Neurotoxicity Research · doi:10.1007/s12640-017-9860-4 · Cited by 78
“Secondly, major depression is accompanied by indicants of nitrosative stress as indicated by increased inducible nitric oxide (NO) synthase activity and nitration and nitrosylation of proteins (Gałecki et al. 2012; Maes 2008; Maes et al. 2011b, c; Liu et al. 2015).”
Kuwano, N., Kato, T. A., Setoyama, D., Sato-Kasai, M., Shimokawa, N., Hayakawa, K., Ohgidani, M., Sagata, N., Kubo, H., Kishimoto, J., et al. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.01.014 · Cited by 69
Maes, M. H. J., Rachayon, M., Jirakran, K., Sodsai, P., Klinchanhom, S., Gałecki, P., Sughondhabirom, A., & Basta‐Kaim, A. (2022) · Cells · doi:10.3390/cells11071183 · Cited by 76
“The immunological response is intimately linked to redox mechanisms including increased formation of reactive oxygen and nitrogen species (RONS), diminished antioxidant defenses, and indicators of enhanced nitro-oxidative stress toxicity (OSTOX), all of which are found in MDD and BD [6-8].”
BackgroundGomes, C. C., Martinho, F. C., Barbosa, D. S., Antunes, L. S., Póvoa, H. C. C., Baltus, T. H. L., Morelli, N. R., Vargas, H. O., Nunes, S. O. V., Anderson, G., et al. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0545-z · Cited by 77
Cecerska-Heryć, E., Polikowska, A., Serwin, N., Roszak, M., Grygorcewicz, B., Heryć, R., Michalczyk, A., & Dołęgowska, B. (2022) · Neurochemistry International · doi:10.1016/j.neuint.2021.105269 · Cited by 68
Bansal, Y., Singh, R., Parhar, I., Kuhad, A., & Soga, T. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00452 · Cited by 68
A neuro-immune, neuro-oxidative and neuro-nitrosative model of prenatal and postpartum depression
Roomruangwong, C., Anderson, G., Berk, M., Stoyanov, D., Carvalho, A. F., & Maes, M. H. J. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.09.015 · Cited by 67
“diverse oxidative insults with lowered levels increasing the susceptibility to lipid peroxidation, including from raised levels of MDA (Jiménez-Fernández et al., 2015; Liu et al., 2015), and protein oxidation, as indicated by an increase in advanced oxidation protein products (AOPP) (Gomes et al.”
BackgroundHarnessing neuroplasticity: modern approaches and clinical future
Sasmita, A. O., Kuruvilla, J., & Ling, A. P. K. (2018) · International Journal of Neuroscience · doi:10.1080/00207454.2018.1466781 · Cited by 74
“combating neurodegeneration and neuropsychological disorders, such as depressive disorders [135] and autism”
BackgroundThe Many Faces of Mitochondrial Dysfunction in Depression: From Pathology to Treatment
Caruso, G., Benatti, C., Blom, J. M. C., Caraci, F., & Tascedda, F. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00995 · Cited by 65
Wigner, P., Czarny, P. L., Gałecki, P., Su, K., & Śliwiński, T. (2017) · Psychiatry Research · doi:10.1016/j.psychres.2017.09.045 · Cited by 69
Li, X., Wu, T., Yu, Z., Li, T., Zhang, J., Zhang, Z., Cai, M., Zhang, W., Xiang, J. Y., & Cai, D. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.01.137 · Cited by 66
Kang, D., Kim, Y., & Je, Y. (2018) · European Journal of Clinical Nutrition · doi:10.1038/s41430-018-0121-2 · Cited by 69
Manosso, L. M., Camargo, A., Dafré, A. L., & Rodrigues, A. L. S. (2020) · Nutritional Neuroscience · doi:10.1080/1028415x.2020.1853417 · Cited by 68
“levels as well as increased free radicals and oxidative damage product levels in the serum of depressed patients [91].”
BackgroundKatrenčíková, B., Vaváková, M., Paduchová, Z., Nagyová, Z., Garaiová, I., Muchová, J., Ďuračková, Z., & Trebatická, J. (2021) · Antioxidants · doi:10.3390/antiox10081256 · Cited by 69
“It is assumed that oxidative stress and inflammation can influence each other [49].”
BackgroundMartín‐Hernández, D., Tendilla‐Beltrán, H., Madrigal, J. L. M., García‐Bueno, B., Leza, J. C., & Caso, J. R. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1096-7 · Cited by 67
COVID-19 and ethnicity: A novel pathophysiological role for inflammation
Vepa, A., Bae, J. P., Ahmed, F., Pareek, M., & Khunti, K. (2020) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2020.06.056 · Cited by 63
Moraes, J. B., Maes, M. H. J., Roomruangwong, C., Bonifácio, K. L., Barbosa, D. S., Vargas, H. O., Anderson, G., Kubera, M., Carvalho, A. F., & Nunes, S. O. V. (2018) · Metabolic Brain Disease · doi:10.1007/s11011-018-0209-3 · Cited by 60
“droxyl) as indicated by increased levels of superoxide dismutase (SOD) and peroxides coupled with lowered levels of catalase (Liu et al. 2015; Maes et al. 2010); c) oxidative damage to lipids”
BackgroundInfluentialGuan, Y., Wang, J., Wu, X., Song, L., Wang, Y., Gong, M., & Li, B. (2021) · Brain Research · doi:10.1016/j.brainres.2021.147661 · Cited by 61
Why Should Psychiatrists and Neuroscientists Worry about Paraoxonase 1?
Moreira, E. G., Boll, K. M., Correia, D. G., Soares, J. F., Rigobello, C., & Maes, M. H. J. (2018) · Current Neuropharmacology · doi:10.2174/1570159x17666181227164947 · Cited by 59
“In a recent meta-analysis study [39], the authors reported that serum PON1 activity was lower in patients with acute episodes than controls (studies used were [36-38]), but PON1 activity was not increased following antidepressant therapy (studies used were [36, 37]).”
Association between the dietary inflammatory index and common mental health disorders profile scores
Haghighatdoost, F., Feizi, A., Esmaillzadeh, A., Feinle-Bisset, C., Keshteli, A. H., Afshar, H., & Adibi, P. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2018.08.016 · Cited by 55
Gawali, N. B., Bulani, V. D., Chowdhury, A. A., Deshpande, P. S., Nagmoti, D. M., & Juvekar, A. R. (2016) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2016.07.004 · Cited by 60
Adherence to a Mediterranean Diet Is Associated with Lower Depressive Symptoms among U.S. Adults
Oddo, V. M., Welke, L., McLeod, A., Pezley, L., Xia, Y., Maki, P. M., Koenig, M. D., Kominiarek, M. A., Langenecker, S. A., & Tussing-Humphreys, L. M. (2022) · Nutrients · doi:10.3390/nu14020278 · Cited by 64
Ding, J., & Zhang, Y. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.857823 · Cited by 62
“Since the oxidative stress is also considered to play a significant role in the pathophysiology of depression (17, 18), it seems naturally that dietary vitamin C and E intake is negatively associated with depression.”
BackgroundFlavonols in Action: Targeting Oxidative Stress and Neuroinflammation in Major Depressive Disorder
Jembrek, M. J., Oršolić, N., Karlović, D., & Peitl, V. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24086888 · Cited by 63
Barbosa, M. L., de Menezes, A. P. M., de Aguiar, R. P. S., Sousa, J. M. D. C. E., Cavalcante, A. A. D. C. M., & Maluf, S. W. (2020) · Neurology Psychiatry and Brain Research · doi:10.1016/j.npbr.2020.02.006 · Cited by 73
Molecular Mechanisms Underlying the Anti-depressant Effects of Resveratrol: a Review
de Oliveira, M. R., Chenet, A. L., Duarte, A. R., Scaini, G., & Quevedo, J. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0680-6 · Cited by 57
High Vitamin C Status Is Associated with Elevated Mood in Male Tertiary Students
Pullar, J., Carr, A., Bozonet, S., & Vissers, M. (2018) · Antioxidants · doi:10.3390/antiox7070091 · Cited by 52
“Oxidative stress markers are also elevated in patients with depression [51].”
BackgroundJiang, C.-Y., Qin, X., Yuan, M.-M., Lu, G.-J., & Cheng, Y. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/9501427 · Cited by 55
Döme, P., Tombor, L., Lazáry, J., Gonda, X., & Rihmer, Z. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.12.015 · Cited by 53
Simeonova, D., Stoyanov, D., Leunis, J., Carvalho, A. F., Kubera, M., Murdjeva, M., & Maes, M. (2020) · Neurotoxicity Research · doi:10.1007/s12640-019-00126-7 · Cited by 51
Zhu, Y., Li, S.-L., Zhu, C., Wang, W., Zuo, W.-F., & Qiu, X. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.112832 · Cited by 51
Exploring the Impact of Flavonoids on Symptoms of Depression: A Systematic Review and Meta-Analysis
Alì, S., Corbi, G., Maes, M. H. J., Scapagnini, G., & Davinelli, S. (2021) · Antioxidants · doi:10.3390/antiox10111644 · Cited by 53
“An altered redox status has been confirmed in the central nervous system (CNS) of depressed patients and oxidative disturbances have been associated with lowered concentrations of several endogenous antioxidant enzymes [6].”
BackgroundWei, Y., Feng, J., Ma, J., Chen, D., Xu, H., Yin, L., & Chen, J. (2022) · BMC Psychiatry · doi:10.1186/s12888-022-03775-9 · Cited by 48
“A meta analysis involving 115 articles showed that albumin levels in patients with MDD were lower than that in controls, and were increased after antidepressant therapy [58].”
BackgroundSelf-citationMatraszek, R., Chwil, M., Terlecka, P., & Skoczylas, M. M. (2019) · Pharmaceuticals · doi:10.3390/ph12040172 · Cited by 50
Goh, X. X., Tang, P. Y., & Tee, S. F. (2021) · Psychiatry Investigation · doi:10.30773/pi.2020.0417 · Cited by 50
Roles of Gasotransmitters in Synaptic Plasticity and Neuropsychiatric Conditions
Shefa, U., Kim, D., Kim, M., Jeong, N. Y., & Jung, J. (2018) · Neural Plasticity · doi:10.1155/2018/1824713 · Cited by 51
“A meta-analysis revealed disorders in neurooxidative pathways in major depression [79].”
BackgroundSex-Specific Differences in Redox Homeostasis in Brain Norm and Disease
Ruszkiewicz, J. A., Miranda‐Vizuete, A., Tinkov, A. A., Геннадиевна, С. М., Skalny, A. V., Tsatsakis, A. M., & Aschner, M. (2019) · Journal of Molecular Neuroscience · doi:10.1007/s12031-018-1241-9 · Cited by 48
Maes, M. H. J., Congio, A. C., Moraes, J. B., Bonifácio, K. L., Barbosa, D. S., Vargas, H. O., Morris, G., Puri, B. K., Michelin, A. P., & Nunes, S. O. V. (2018) · BioMolecular Concepts · doi:10.1515/bmc-2018-0010 · Cited by 48
Rappeneau, V., Wilmes, L., & Touma, C. (2020) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2020.103555 · Cited by 52
The Reactive Species Interactome in the Brain
Malard, E., Valable, S., Bernaudin, M., Pérès, E. A., & Châtre, L. (2021) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8238 · Cited by 50
Sipahi, H., Mat, A. F., Özhan, Y., & Aydın, A. (2022) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026623666221223111309 · Cited by 53
Pinzi, M., Fagiolini, A. M., Koukouna, D., Gualtieri, G., Rescalli, M. B., Pierini, C., Pardossi, S., Patrizio, B., & Cuomo, A. (2025) · Cells · doi:10.3390/cells14191558 · Cited by 53
“Clinical studies consistently show elevated peripheral markers of oxidative stress in mood disorders, including malondialdehyde (MDA), 8-hydroxy-2 ′ -deoxyguanosine (8-OHdG), and isoprostanes, alongside reduced antioxidant defenses such as total antioxidant capacity, uric acid, and zinc [24,25].”
InfluentialWang, J., Chen, R., Liu, C., Wu, X., & Zhang, Y. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174396 · Cited by 47
Song, L., Wu, X., Wang, J., Guan, Y., Zhang, Y., Gong, M., Wang, Y., & Li, B. (2021) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2021.09.002 · Cited by 46
Metadata
- Authors
- Liu, T., Zhong, S., Liao, X., Chen, J., He, T., Lai, S., & Jia, Y.
- Affiliations
- Jinan University (CN)
- Corresponding author
- Jia, Yanbin
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-10-07
- Volume
- 10
- Issue
- 10
- Pages
- e0138904
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4596519
- OpenAlex
- W2105160377
- Cited by
- 485
- References
- 125
- Citations by year
- 2026: 30 · 2025: 41 · 2024: 42 · 2023: 54 · 2022: 51 · 2021: 78 · 2020: 63 · 2019: 39 · 2018: 43 · 2017: 27 · 2016: 15
- FWCI
- 2.99
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Jinan University
- Department of Education of Guangdong Province
- Topics
- Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- depression, oxidative stress, total antioxidant capacity, antioxidants, paraoxonase, uric acid, malondialdehyde, 8-isoprostane, free radicals, oxidative damage, antidepressant treatment, acute depressive episode, antioxidant supplementation
- MeSH terms
- Albumins, Antidepressive Agents, Antioxidants, Ascorbic Acid, Cross-Sectional Studies, Depression, Depressive Disorder, Humans, Lipoproteins, HDL, Malondialdehyde, Uric Acid, Lipid Peroxidation, Biomarkers, Case-Control Studies, Oxidative Stress, F2-Isoprostanes, Aryldialkylphosphatase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.